Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin – production and release in children and adolescents with ADHD and chronic sleep problems
2019-000211-80Phase 4Terminated
- Sponsor
- Child and Adolescent Psychiatry, South Jutland
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of melatonin in attention deficit hyperactivity disorder (ADHD) and Insomnia, sponsored by Child and Adolescent Psychiatry, South Jutland. Primary endpoint: Sleep onset latency. Started Jun 2019; status: terminated.
02
Drugs
melatonin
03
Conditions
attention deficit hyperactivity disorder (ADHD)Insomnia
Beyond the preview
Go deeper on 2019-000211-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000211-80.